MedPath

Efficacy of Narrow Band Imaging (NBI) and Computed Tomography (CT) following head and neck cancer treatment.

Not Applicable
Not yet recruiting
Conditions
Lung cancer
Head and Neck Cancer
Surveillance for second primary cancer
Cancer - Head and neck
Cancer - Lung - Non small cell
Registration Number
ACTRN12616000581460
Lead Sponsor
Royal Brisbane and Womens Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients 3-5 years post completion of curative treatment of Head and Neck Cancer ( either surgery or chemoradiation.)

Exclusion Criteria

Severe COPD or active coronary artery disease making bronchoscopy unsafe

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.